Your session is about to expire
← Back to Search
Diagnostic Test
Multi-site Validation and Application of a Consensus DSC-MRI Protocol
N/A
Waitlist Available
Led By Chad Quarles, PhD
Research Sponsored by St. Joseph's Hospital and Medical Center, Phoenix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is to show that MRI is a useful tool for diagnosing brain tumors.
Eligible Conditions
- Gliomas
- Gliosarcoma
- Glioblastoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Histologic measures of tumor fraction
Secondary study objectives
Determine overall survival (OS) in recurrent GBM patients.
Determine the repeatability of rCBV measured with the consensus DSC-MRI protocol.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: DSC-MRI scanExperimental Treatment1 Intervention
All subjects will receive a double dose injection protocol that will be split into multiple doses for sequential DSC-MRI scans.
Find a Location
Who is running the clinical trial?
St. Joseph's Hospital and Medical Center, PhoenixLead Sponsor
67 Previous Clinical Trials
17,284 Total Patients Enrolled
Chad Quarles, PhDPrincipal InvestigatorBarrow Neurological Institute